The continued suppression of clinical trial data is an insult to patients and volunteers, writes Ian Bushfield
The number of flawed papers making it through peer review and into publications tells us something needs to change, say Adam Marcus and Ivan Oransky
Not on Twitter? Social media and research go hand in hand, says Rebecca Nesbit
Mike Silverman on the lessons to be learned from privatising key scientific services
Judge GM crops on their properties, not the technique that made them – and we can start saving lives, says Professor Klaus Ammann
Biologists should not underestimate how valuable their skills are in management and business. Dr James Deverill and Dr Alison Howell explain how to bridge the gap
Researchers should be more receptive to the concept of patenting, says Robert Andrews
Page 14 of 16
